TrxR/EGFR-IN-1, CAS [[3038386-42-1]] Preis auf Anfrage

Produktübersicht

• Artikelname: TrxR/EGFR-IN-1, CAS [[3038386-42-1]] Preis auf Anfrage
• Artikelnummer: TGM-T205519
• Hersteller Artikelnummer: T205519
• Alternativnummer: TGM-T205519-10MG,TGM-T205519-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

TrxR/EGFR-IN-1 (Compound L1Au2) is a TrxR/EGFR inhibitor with activity against both gefitinib-sensitive and -resistant lung cancer, effectively suppressing tumor proliferation and promoting apoptosis. It enhances GPX4 degradation through autophagosome-lysosome and proteasome pathways, leading to ferroptosis. Additionally, it induces endoplasmic reticulum stress and triggers immunogenic cell death, making it applicable for studies on gefitinib-resistant lung cancer.

Produkteigenschaften

• Molekulargewicht: 710.878
• CAS Nummer: [3038386-42-1]
• Formel: C24H24AuClFN6O2P
• Target-Kategorie: Apoptosis|||EGFR|||Ferroptosis

Bilder

T205519